Emerald Health Therapeutics, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was CAD 11.740 million compared to CAD 20.319 million a year ago. Operating income was CAD 54.553 million compared to CAD 116.135 million a year ago. Net loss was CAD 42.952 million compared to CAD 111.141 million a year ago. Basic earnings per share from continuing operations was CAD 0.22 compared to CAD 0.75 a year ago.